Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.9 USD | -0.06% | -3.45% | +1.36% |
Apr. 25 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
Financials (USD)
Sales 2024 * | 538M | Sales 2025 * | 579M | Capitalization | 840M |
---|---|---|---|---|---|
Net income 2024 * | 40M | Net income 2025 * | 57M | EV / Sales 2024 * | 1.81 x |
Net Debt 2024 * | 132M | Net Debt 2025 * | 79M | EV / Sales 2025 * | 1.59 x |
P/E ratio 2024 * |
21.4
x | P/E ratio 2025 * |
15
x | Employees | 3,500 |
Yield 2024 * |
0.22% | Yield 2025 * |
0.22% | Free-Float | 98.96% |
Latest transcript on Core Laboratories Inc.
1 day | -0.06% | ||
1 week | -0.11% | ||
Current month | -4.48% | ||
1 month | +12.44% | ||
3 months | +15.78% | ||
6 months | -0.94% | ||
Current year | +1.36% |
Managers | Title | Age | Since |
---|---|---|---|
Lawrence Bruno
CEO | Chief Executive Officer | 64 | - |
Christopher Hill
DFI | Director of Finance/CFO | 54 | - |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Curtis Anastasio
BRD | Director/Board Member | 67 | 23-06-27 |
Director/Board Member | 71 | 19-12-31 | |
Director/Board Member | 74 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 17.9 | -0.06% | 532,960 |
24-06-03 | 17.91 | -4.43% | 471,560 |
24-05-31 | 18.74 | +2.24% | 680,668 |
24-05-30 | 18.33 | +1.10% | 254,564 |
24-05-29 | 18.13 | -2.21% | 303,203 |
Delayed Quote Nyse, June 04, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.36% | 840M | |
-.--% | 7.64B | |
-11.60% | 2.72B | |
-20.28% | 2.61B | |
-25.63% | 1.88B | |
-11.06% | 1.06B | |
-9.36% | 1.03B | |
-1.66% | 751M | |
-21.43% | 743M | |
-29.30% | 655M |
- Stock Market
- Equities
- CLB Stock